Enterprise League logo
Lantern Pharma Inc. (Nasdaq: LTRN) Logo

Lantern Pharma Inc. (Nasdaq: LTRN)

Dallas, United States (US) · Health and Medical

Do you work at Lantern Pharma Inc. (Nasdaq: LTRN)?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Lantern Pharma is a clinical-stage pharmaceutical company based in Dallas, Texas, focused on developing innovative precision cancer therapies.We are dedicated to rescuing and revitalizing abandoned cancer drugs, leveraging cutting-edge machine learning techniques, genomic data, and precision oncology trials to identify new treatment opportunities.

Overview

Lantern Pharma is a clinical-stage pharmaceutical company based in Dallas, Texas, focused on developing innovative precision cancer therapies.

We are dedicated to rescuing and revitalizing abandoned cancer drugs, leveraging cutting-edge machine learning techniques, genomic data, and precision oncology trials to identify new treatment opportunities. Our core mission is to accelerate the development of personalized cancer therapy through AI and genomic-based patient stratification.

Lantern Pharma utilizes its proprietary RADR platform to provide rapid, meaningful insights into patient populations and drug mechanisms, ultimately driving the creation of more effective and targeted cancer treatments. We are committed to transforming the landscape of oncology drug development and improving patient outcomes.

Founded in 2013, Lantern Pharma currently employs 28 people and is publicly traded on Nasdaq under the ticker LTRN.
Visit Official Website

Most teams do this before shortlisting


Contact Details

admin@lanternpharma.com

Dallas, United States (US), 1920 McKinney Ave

+1

Founded

2013

Company Type

Public Limited Company

Employees

20-30

Categories

Biopharma
Life Science
Biotechnology

Keywords

#biotechnology

#cancer drug development

#precision medicine

#biomarkers

#genetic screen

#companion diagnostics

#precisiononcology

#artificial intelligence

#patient stratification

#drug rescue

#drug repurposing

Awards

• 2026 OpenSee all

Services

Default Product Image
RADR Platform
Biotechnology

Lantern Pharma’s proprietary RADR platform utilizes artificial intelligence and machine learning to rapidly analyze genomic data and patient populations, providing critical insights for drug development and patient stratification. This platform is instrumental in our efforts to rescue and revitalize abandoned cancer drugs and identify new treatment opportunities.

N/A

Companies teams usually look at after Lantern Pharma Inc. (Nasdaq: LTRN)

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.